Table 4

Cost-effectiveness of mammography screening strategies in Catalonia (Spain)

Scenario

Cost

ΔCost

Effect

ΔEffect

ΔC/ΔE (ICER)


(×106 €)

(×106 €)

LE

ΔLE

€/LE


Bg

127.3

0

B 50-69

143.4

16.2

567

567

28,465

B 50-70

144.6

1.1

590

23

49,184

B 50-74

147.0

2.5

640

50

50,188

A 50-74

167.0

20.0

757

117

170,304

A 45-74

182.1

15.1

803

46

330,098

A 40-74

201.5

19.4

837

34

573,062

A 40-79

210.4

8.9

849

12

715,941


YL

ΔYL

€/YL


Bg

127.3

0

B 50-69

143.4

16.2

4,691

4,691

3,444

B 45-69

151.5

8.1

5,842

1,151

7,015

A 45-69

176.0

24.4

7,917

2,075

11,777

A 40-69

195.4

19.4

9,117

1,200

16,166

A 40-74

201.5

6.2

9,370

253

24,415

A 40-79

210.4

8.9

9,390

20

451,370


QALY

ΔQALY

€/QALY


Bg

127.3

0

B 50-69

143.4

16.2

3,614

3,614

4,469

B 45-69

151.5

8.1

4,447

833

9,694

B 45-74

153.9

2.4

4,633

186

12,633

A 45-69

176.0

22.1

5,979

1,346

16,411

A 40-69

195.4

19.4

6,756

777

24,975

A 40-74

201.5

6.2

6,987

231

26,720


Incremental cost per effect (LE, YL and QALY) assuming a cohort of 100,000 women at birth. Dominated or extended-dominated strategies are not included.

Carles et al. BMC Cancer 2011 11:192   doi:10.1186/1471-2407-11-192

Open Data